Synthesis and discovery of polyisopentenylated acylphloroglucinols with selective antiproliferative activity against breast cancer cells.

Authors

Hong-Yuan Wang, Yong Li, Jie Wei, Hong-Yan Han, Chen Yang, Li-Dong Shao, Xing-Ren Li, Gang Xu

Published in

Bioorganic & medicinal chemistry letters. Pages 130785. Sep 26, 2026. Epub Sep 26, 2026.

Abstract

Twenty-seven polyisopentenylated acylphloroglucinols were designed and synthesized through Friedel-Crafts acylation and alkylation reactions. Among these compounds, a C-farnesylated acylphloroglucinol 13b exhibited selective antiproliferative activity against HER2+ breast cancer cells (SKBr3 and JIMT-1) and triple-negative breast cancer (TNBC) cells (MDA-MB-468), with IC₅₀ values ranging from 7.05 to 9.48 μM. Moreover, compound 13b showed low toxicity toward normal breast epithelial cells MCF-10A (CC₅₀ = 20.1 μM), indicating a favorable safety profile with selectivity indices (SI) ranging from 2.1 to 2.9. Mechanistic studies revealed that 13b inhibits breast cancer cell growth by causing G₂/M phase arrest and inducing apoptosis. These findings provide valuable insights for the development of selective antiproliferative agents against breast cancer based on polyisopentenylated acylphloroglucinol scaffold.

PMID:
42800619
Bibliographic data and abstract were imported from PubMed on 27 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.